STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Cohen Milstein Reminds Paragon 28, Inc. Investors of Nov. 29, 2024 Lead Plaintiff Deadline

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Negative)
Tags

Cohen Milstein has announced a securities class action lawsuit against Paragon 28 (NYSE:FNA), a medical device company, regarding alleged false and misleading statements about financial statements and internal controls. The lawsuit covers investors who purchased shares between May 5, 2023, and September 20, 2024. Investors who suffered significant losses during this period have until November 29, 2024, to request appointment as lead plaintiff. The complaint, filed in the U.S. District Court for the District of Colorado, alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by current and former officers.

Loading...
Loading translation...

Positive

  • None.

Negative

  • Company faces securities class action lawsuit over alleged false financial statements
  • Potential legal liabilities and associated costs from securities fraud allegations
  • Questions raised about internal control effectiveness

Insights

This class action lawsuit against Paragon 28 raises significant concerns about alleged financial statement misrepresentations and internal control issues. The case, filed in Colorado District Court, potentially exposes the company to substantial financial liability and reputational damage. The specified class period of over 16 months (May 2023 to September 2024) suggests systematic issues rather than isolated incidents. Cohen Milstein's track record in securities litigation, particularly their $1 billion recovery in the Wells Fargo case, indicates this is a serious legal challenge. The November 29, 2024 deadline for lead plaintiff designation is important for affected investors who experienced significant losses. The allegations of violations of Sections 10(b) and 20(a) of the Securities Exchange Act could result in material financial penalties and mandatory corporate governance reforms if proven.

WASHINGTON, DC / ACCESSWIRE / November 19, 2024 / Cohen Milstein reminds investors who lost money on securities of Paragon 28, Inc. ("Paragon 28" or the "Company") (NYSE:FNA) purchased between May 5, 2023 and September 20, 2024 that they can contact Cohen Milstein Sellers & Toll PLLC to learn about a pending securities class action lawsuit.

To learn about your legal options, click here to connect with a member of the Cohen Milstein team or contact Partner Molly J. Bowen at (202) 408-4600 or mbowen@cohenmilstein.com.

BACKGROUND: On October 18, 2024 a complaint against medical device company Paragon 28, Inc. was filed in the U.S. District Court for the District of Colorado. The complaint alleges that certain current and former officers made false and misleading statements to investors about financial statements and internal controls in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

NEXT STEPS: If you suffered a significant loss in Paragon 28 shares purchased during the proposed class period of May 5, 2023 to September 20, 2024, and are interested in serving as lead plaintiff in this action, you have until November 29, 2024 to request that the court appoint you as lead plaintiff. You are not required to file a lead plaintiff motion to share in any recovery in this action as a class member.

OUR FIRM: With more than 100 attorneys in eight offices, Cohen Milstein is one of the largest plaintiff-side law firms in the U.S., with more than four decades of experience litigating securities fraud cases. We have recovered billions of dollars to investors, including $1 billion last year as co-lead counsel in In re Wells Fargo & Company Securities Litigation, and are perennially recognized as one of the best securities practice groups in the country by legal publications such as The National Law Journal, Law360, Chambers USA, and The Legal 500. For more information visit www.cohenmilstein.com.

Prior results do not guarantee a similar outcome. Attorney Advertising.

CONTACT INFORMATION:

Molly Bowen, Esq.
Licensed in DC, Florida, and Ohio
Cohen Milstein Sellers & Toll PLLC
1100 New York Avenue, N.W., Fifth Floor
Washington, D.C. 20005
Telephone: (888) 240-0775 or (202) 408-4600
Email: mbowen@cohenmilstein.com
Website: www.cohenmilstein.com

SOURCE: Cohen Milstein Sellers & Toll PLLC



View the original press release on accesswire.com

FAQ

What is the deadline for Paragon 28 (FNA) investors to file as lead plaintiff?

Investors have until November 29, 2024, to request appointment as lead plaintiff in the securities class action lawsuit.

What period does the Paragon 28 (FNA) class action lawsuit cover?

The class action covers investors who purchased Paragon 28 shares between May 5, 2023, and September 20, 2024.

What are the allegations against Paragon 28 (FNA) in the lawsuit?

The lawsuit alleges that company officers made false and misleading statements about financial statements and internal controls, violating Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

Where was the Paragon 28 (FNA) securities class action lawsuit filed?

The lawsuit was filed in the U.S. District Court for the District of Colorado on October 18, 2024.
Paragon 28 Inc

NYSE:FNA

FNA Rankings

FNA Latest News

FNA Stock Data

1.09B
56.99M
Surgical and Medical Instrument Manufacturing
Surgical & Medical Instruments & Apparatus
Link
US
ENGLEWOOD